BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/14/2017 10:42:00 AM | Browse: 1264 | Download: 1512
 |
Received |
|
2016-03-09 09:35 |
 |
Peer-Review Started |
|
2016-03-09 21:30 |
 |
To Make the First Decision |
|
2016-04-14 08:44 |
 |
Return for Revision |
|
2016-04-20 14:40 |
 |
Revised |
|
2016-04-29 20:26 |
 |
Second Decision |
|
2016-05-17 10:48 |
 |
Accepted by Journal Editor-in-Chief |
|
2016-05-17 12:16 |
 |
Accepted by Executive Editor-in-Chief |
|
2016-06-02 15:36 |
 |
Articles in Press |
|
2016-06-02 15:37 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-12-23 22:24 |
 |
Publish the Manuscript Online |
|
2017-01-14 10:27 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Donal Tighe and Deirdre McNamara |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
European Crohn’s and Colitis Organisation |
|
|
Corresponding Author |
Dr. Donal Tighe, Department of Gastroenterology, Adelaide and Meath Incorporating the National Children's Hospital Tallaght, School of Clinical Medicine, Trinity College Dublin, Trinity Academic Gastroenterology Group, AMNCH Tallaght, Tallaght, Dublin 24, Ireland. tighedo@tcd.ie |
Key Words |
Inflammatory bowel disease; Ulcerative colitis; Immunomonitoring; loss of response; Anti-TNFα trough and antibody levels; Crohn's disease; immunogenicity |
Core Tip |
Immunomonitoring is being increasingly used to optimise response rates in inflammatory bowel disease. The aim of this review article is to explore the available literature, and to understand the rationale for using immunomonitoring and to see how this approach can be best incorporated into inflammatory bowel disease treatment algorithms. The focus of this review article is the role for immunomonitoring at the key points of induction, and at loss of response. It will emphasise the possible advantages of immunomonitoring. It will define optimal trough levels, plus targets required to achieve mucosal healing, and help alter the natural history of the disease. |
Publish Date |
2017-01-14 10:27 |
Citation |
Tighe D, McNamara D. Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease. World J Gastroenterol 2017; 23(3): 414-425 |
URL |
http://www.wjgnet.com/1007-9327/full/v23/i3/414.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v23.i3.414 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345